跳至主要内容
临床试验/NL-OMON22988
NL-OMON22988招募中不适用

TripleFive Pilot Study investigating the feasibility and initial safety of the (L)IMA bed application of ACF-Matrix haemostat in 10 CABG patients.

Gelita Medical0 个研究点目标入组 10 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
10

研究概览

简要总结

/A

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Patients 18 years or older;
  • 2. Patients demonstrating signs and symptoms of coronary ischaemia and/or stenosis clinically considered suitable for correction by CABG surgery;

排除标准

  • 1. Patients coming in for an emergency CABG procedure;
  • 2. Patients coming in for a re- CABG procedure;

研究者

发起方
Gelita Medical

相似试验